Business

GE HealthCare Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection

New offering provides an all-in-one AI platform optimized for mammography, that seamlessly integrates artificial intelligence (AI) applications from iCAD to

articleGe Healthcare Technologies Inc.November 27, 20234/company/ge-healthcare-technologies-inc/news/ge-healthcare-releases-mybreastai-suite-to-support-clinicians-in-accelerating-breast-cancer-detection
GE HealthCare Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection

About this update from Ge Healthcare Technologies Inc.

[{"type":"text","content":"\n\nNew offering provides an all-in-one AI platform optimized for mammography, that seamlessly integrates artificial intelligence (AI) applications from iCAD to aid clinicians in breast cancer detection as well as breast density assessment and notification.\n\n\n\n CHICAGO--(BUSINESS WIRE)--\nToday GE HealthCare (Nasdaq: GEHC) announced the release of a new, all-in-one platform of artificial intelligence (AI) apps to support clinicians with breast cancer detection and improved workflow productivity called MyBreastAI Suite*. With this initial release, MyBreastAI Suite integrates three AI applications from iCAD including ProFound AI for DBT, SecondLook for 2D Mammography and PowerLook Density Assessment to help support early detection and improve patient outcomes, as well as help radiology departments improve operational productivity.\n\n\nAs the global cancer burden rises, radiologists face increasing challenges such as burnout, workforce attrition, and patient backlogs, placing strain on and testing the resiliency of health systems today. In ongoing efforts to combat breast cancer, the healthcare community remains committed to early detection by leveraging methods, like screening mammography, that have proven to be effective in identifying early breast cancers and reducing breast cancer-specific mortality.1 However, with breast cancer now surpassing lung cancer as the most commonly diagnosed cancer worldwide,2 clinicians are seeking tools that can address issues related to access, burnout, variability, equity, and cost in breast imaging to elevate and enhance the detection and diagnosis of breast cancer.\n\n\nThe introduction of MyBreastAI Suite aims to address these challenges by providing an all-in-one platform that can seamlessly deploy AI to breast imaging workflow. With this initial release, MyBreastAI Suite integrates three AI applications from iCAD’s ProFound Breast Health Suite, including:\n\n\n\nProFound AI for DBT: Trained with one of the largest available 3D image datasets, ProFound AI for DBT provides radiologists with crucial information, such as lesion Certainty of Finding and Case Scores, which assists in prioritizing caseloads, clinical decision-making, and may help reduce burnout.3\n\n\n\nSecondLook for 2D Mammography: The SecondLook Computer-Aided Detection (CAD) system for mammography is intended to identify a...

More updates from Ge Healthcare Technologies Inc.